Sijing Zhou

1.1k total citations
60 papers, 742 citations indexed

About

Sijing Zhou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Sijing Zhou has authored 60 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Sijing Zhou's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (12 papers) and Pulmonary Hypertension Research and Treatments (11 papers). Sijing Zhou is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (12 papers) and Pulmonary Hypertension Research and Treatments (11 papers). Sijing Zhou collaborates with scholars based in China, United States and Singapore. Sijing Zhou's co-authors include Ran Wang, Yi Liu, Guanghe Fei, Daxiong Zeng, Peipei Wu, Huihui Jiang, Xuan Xu, Min Li, Ke Zhu and Xianhe Xie and has published in prestigious journals such as The Science of The Total Environment, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Sijing Zhou

54 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sijing Zhou China 17 362 327 295 151 104 60 742
Shencun Fang China 14 331 0.9× 374 1.1× 201 0.7× 90 0.6× 88 0.8× 40 731
John R. Barber United States 15 169 0.5× 220 0.7× 142 0.5× 174 1.2× 100 1.0× 40 652
Zheng Xu China 18 357 1.0× 143 0.4× 186 0.6× 63 0.4× 125 1.2× 39 735
Yun Sun China 12 251 0.7× 180 0.6× 275 0.9× 121 0.8× 52 0.5× 25 551
Xiyi Wei China 16 277 0.8× 262 0.8× 225 0.8× 136 0.9× 84 0.8× 37 700
Su Xie China 8 246 0.7× 227 0.7× 116 0.4× 43 0.3× 77 0.7× 27 562
Shimin Chen China 14 346 1.0× 101 0.3× 265 0.9× 73 0.5× 34 0.3× 41 651
Tao Zhao China 15 181 0.5× 205 0.6× 126 0.4× 93 0.6× 39 0.4× 38 544
Tomasz Powrózek Poland 16 402 1.1× 272 0.8× 347 1.2× 210 1.4× 19 0.2× 77 823
Kimberly E. White United States 10 218 0.6× 276 0.8× 84 0.3× 53 0.4× 93 0.9× 11 708

Countries citing papers authored by Sijing Zhou

Since Specialization
Citations

This map shows the geographic impact of Sijing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijing Zhou more than expected).

Fields of papers citing papers by Sijing Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sijing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijing Zhou. The network helps show where Sijing Zhou may publish in the future.

Co-authorship network of co-authors of Sijing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Sijing Zhou. A scholar is included among the top collaborators of Sijing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sijing Zhou. Sijing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Binbin, Sijing Zhou, Rui Han, et al.. (2024). RELA-mediated upregulation of LINC03047 promotes ferroptosis in silica-induced pulmonary fibrosis via SLC39A14. Free Radical Biology and Medicine. 223. 250–262. 7 indexed citations
2.
Wang, Jiling, Min Tang, Min Li, et al.. (2024). A CT-based radiomics predictive nomogram to identify pulmonary tuberculosis from community-acquired pneumonia: a multicenter cohort study. Frontiers in Cellular and Infection Microbiology. 14. 1388991–1388991.
3.
Zheng, Jinping, Xiaojie Wang, Sijing Zhou, et al.. (2024). Global Leadership Initiative on Malnutrition criteria: Clinical benefits for patients with gastric cancer. Nutrition in Clinical Practice. 40(1). 239–251.
4.
Chen, Bijuan, Hui Cheng, Chun-Ping Huang, et al.. (2024). Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study. BMC Cancer. 24(1). 547–547. 3 indexed citations
5.
Sun, Peng, Yue Wang, Sijing Zhou, et al.. (2024). Exploring the shared pathogenic mechanisms of tuberculosis and COVID-19: emphasizing the role of VNN1 in severe COVID-19. Frontiers in Cellular and Infection Microbiology. 14. 1453466–1453466.
6.
Zhang, Binbin, Ling Huang, Rui Han, et al.. (2024). LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway. PA1607–PA1607. 1 indexed citations
7.
Han, Rui, Min Tang, Min Li, et al.. (2023). High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma. Journal of Cancer. 14(17). 3321–3334. 2 indexed citations
8.
Wang, Yue, Sijing Zhou, Min Tang, et al.. (2023). Lung function and nonalcoholic fatty liver disease: a Mendelian randomization study. Archives of Medical Science. 21(1). 197–205. 1 indexed citations
9.
Zhou, Sijing, et al.. (2023). Molecular regulation and therapeutic implications of cell death in pulmonary hypertension. Cell Death Discovery. 9(1). 239–239. 18 indexed citations
10.
Zhou, Sijing, et al.. (2023). Association between urinary phthalate metabolites and chronic obstructive pulmonary disease incidence in US adults: results from NHANES 2007–2018. Environmental Science and Pollution Research. 30(52). 113026–113038. 5 indexed citations
13.
Wang, Yue, Sijing Zhou, Rui Han, et al.. (2022). Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis. International Journal of Medical Sciences. 19(9). 1417–1429. 6 indexed citations
14.
Zhou, Sijing, Ke Zhu, Huihui Jiang, et al.. (2019). Estrogen administration reduces the risk of pulmonary arterial hypertension by modulating the miR-133a signaling pathways in rats. Gene Therapy. 27(3-4). 113–126. 11 indexed citations
15.
Wang, Ran, Sijing Zhou, Peipei Wu, et al.. (2018). Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin. Molecular Therapy — Nucleic Acids. 13. 44–54. 56 indexed citations
16.
Lin, Heng, Lina Li, Sijing Zhou, et al.. (2017). Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer. Molecular and Clinical Oncology. 6(3). 296–306. 3 indexed citations
17.
Wang, Ran, et al.. (2015). Anti-neutrophil cytoplasmic antibody-negative microscopic polyangiitis: A case report and literature review. Experimental and Therapeutic Medicine. 10(2). 749–752. 2 indexed citations
18.
Zhou, Sijing, Min� Li, Daxiong Zeng, et al.. (2015). A Single Nucleotide Polymorphism in 3' Untranslated Region of Epithelial Growth Factor Receptor Confers Risk for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. Cellular Physiology and Biochemistry. 36(1). 166–178. 26 indexed citations
19.
Zhou, Sijing, et al.. (2014). Effects of basic fibroblast growth factor and cyclin D1 on cigarette smoke-induced pulmonary vascular remodeling in rats. Experimental and Therapeutic Medicine. 9(1). 33–38. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026